Li et al. identified a novel 5-gene signature (HOXC10, LOC101928747, CYB561D2, RPL36A, and RPS4XP2) as an independent predictor of prognosis in glioma patients who received radiotherapy [48]. Here, HOXC10 is linked to central nervous system cancer.